Claudia Mugnaini Selected Research

SARS-CoV-2 3C-like proteinase

10/2021

Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Mugnaini Research Topics

Disease

6	Pain (Aches) 05/2023 - 08/2008
4	Neuroinflammatory Diseases 02/2024 - 01/2016
3	Cognitive Dysfunction 02/2024 - 03/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 01/2016
2	COVID-19 03/2022 - 10/2021
2	Tuberculosis (Tuberculoses) 07/2013 - 01/2009
1	Amnesia (Dissociative Amnesia) 02/2024
1	Hyperphagia (Overeating) 10/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2023
1	Neuralgia (Stump Neuralgia) 05/2023
1	Wounds and Injuries (Trauma) 05/2023
1	Hyperalgesia 05/2023
1	Hypoxia (Hypoxemia) 11/2022
1	Alzheimer Disease (Alzheimer's Disease) 07/2022
1	Bacterial Infections (Bacterial Infection) 05/2020
1	Osteoarthritis 01/2020
1	Joint Diseases (Joint Disease) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Glioma (Gliomas) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Hyperuricemia 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2017
1	Multiple Sclerosis 01/2017
1	Reperfusion Injury 12/2012
1	Ischemia 12/2012
1	Epilepsy (Aura) 03/2012
1	Substance-Related Disorders (Drug Abuse) 03/2012
1	Anxiety Disorders (Anxiety Disorder) 03/2012
1	Infections 02/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2005

Drug/Important Bio-Agent (IBA)

5	N- (adamantan- 1- yl)- 4- oxo- 1- pentyl- 6- phenyl- 1,4- dihydroquinoline- 3- carboxamideIBA 05/2023 - 06/2012
4	CannabinoidsIBA 05/2023 - 01/2017
4	CB2 Cannabinoid ReceptorIBA 01/2019 - 12/2012
3	Analgesics (Analgesic Drugs)IBA 05/2023 - 08/2008
3	Formaldehyde (Formol)FDA Link 06/2012 - 08/2008
2	EndocannabinoidsIBA 02/2024 - 05/2023
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2024 - 01/2019
1	Cholinesterases (Cholinesterase)IBA 02/2024
1	Scopolamine (Hyoscine)FDA Link 02/2024
1	Protein Isoforms (Isoforms)IBA 02/2024
1	Neuroprotective AgentsIBA 02/2024
1	Appetite Depressants (Anorectics)IBA 10/2023
1	A 7 (A-7)IBA 05/2023
1	F2-Isoprostanes (F2 Isoprostanes)IBA 11/2022
1	AntioxidantsIBA 11/2022
1	Monoamine Oxidase (MAO)IBA 07/2022
1	cinnamic acidIBA 07/2022
1	AcetylcholinesteraseIBA 07/2022
1	ButyrylcholinesteraseIBA 07/2022
1	EnzymesIBA 07/2022
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	LigandsIBA 03/2022
1	SARS-CoV-2 3C-like proteinaseIBA 10/2021
1	VaccinesIBA 10/2021
1	Ritonavir (Norvir)FDA Link 10/2021
1	Nelfinavir (Viracept)FDA Link 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	Iodoacetic AcidIBA 01/2020
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Xanthine DehydrogenaseIBA 01/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2019
1	HypoxanthineIBA 01/2019
1	immucillin GIBA 01/2019
1	XanthineIBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2019
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2019
1	Myelin Basic ProteinIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Levofloxacin (Levaquin)FDA Link 07/2013
1	Ciprofloxacin (Cipro)FDA LinkGeneric 07/2013
1	4-quinolone-3-carboxylic acidIBA 12/2012
1	GABA-B Receptor AgonistsIBA 03/2012
1	FluoroquinolonesIBA 01/2009
1	SolutionsIBA 02/2007

Therapy/Procedure

2	Therapeutics 10/2021 - 01/2019
1	Oral Administration 05/2023
1	Drug Therapy (Chemotherapy) 08/2005